poisar

Stocks · News reference

These Analysts Revise Their Forecasts On Elevance Health Following Q2 Earnings

BenzingaJul 16, 2026, 12:17 PMAvi Kapoor

Elevance Health Inc. (NYSE:ELV) reported strong Q2 results and raised full-year guidance. Analysts have adjusted price targets for ELV stock.

Reference details

Connected markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

Source
benzinga
Observed
Jul 16, 2026, 12:17 PM
Checked
Jul 16, 2026, 12:17 PM
Cadence
Captured once, then retained as an archive reference
Status
fresh

Keep reading

  1. Zacks Investment ResearchAug 27, 2026, 2:20 PMNa

    Can Cigna's Smart Coverage Help Close Health-Cost Gaps?

    Cigna Healthcare is introducing Smart Coverage, a new benefit option that automatically links medical claims with supplemental benefits to provide eligible members up to $7,000 for covered health events. The program launches January 1, 2027, for mid-sized employers and addresses a significant affordability gap, with nearly 60% of Americans unprepared for health costs. The initiative is designed to increase enrollment in high-deductible plans and boost supplemental product participation.

    Read original at zacks-investment-research